These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32989)

  • 21. [Hepatoprotective action of total liver extract combined with vitamin B 12 vitamin E, and vitamin K in the course of treatment with multiple mycobacterial agents in patients with tuberculosis with chronic liver disease].
    D'Angelo G; Salatino A
    Clin Ter; 1970 Jan; 52(1):61-70. PubMed ID: 5525554
    [No Abstract]   [Full Text] [Related]  

  • 22. [Exepin in pediatric practice].
    Russo U; Romoli F
    Minerva Pediatr; 1971 May; 23(18):811-5. PubMed ID: 5090394
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic efficiency of purified liver extract with an increased amount of vitamin B 12 in coenzymatic form in patients with liver diseases and rheumatoid arthritis].
    Guglielmi G; Garbagnati N; Iaschi P; Ciavarelli F; Ferrantelli D
    Clin Ter; 1969 Nov; 51(3):227-44. PubMed ID: 5407318
    [No Abstract]   [Full Text] [Related]  

  • 24. Antihepatotoxic properties of uridine-diphosphoglucose in liver fluke infection. Experimental fascioliasis in the rat.
    Maffei Facino R; Carini M; Genchi C; Tofanetti O; Casciarri I; Bedoschi D
    Arzneimittelforschung; 1990 Apr; 40(4):490-8. PubMed ID: 2113387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical research on the hepatoprotective and antianemic action of hepatic opotherapy associated with nucleosides in high doses].
    Bestagno M
    Arch Maragliano Patol Clin; 1966; 22(3):299-309. PubMed ID: 5953073
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of treatment with nucleosides, liver extract and vitamin B 12 on various hepatic functional defects and on cellular proliferation of bone marrow in chronic liver diseases].
    Turpini R
    Clin Ter; 1970 Apr; 53(1):9-23. PubMed ID: 5472849
    [No Abstract]   [Full Text] [Related]  

  • 27. [Report on the experiences in the ambutant treatment of hepatopathy with Heparhormforte].
    Ignatius A
    Landarzt; 1965 Sep; 41(25):1090-2. PubMed ID: 5857646
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases].
    Pignattari S; Sarti F; Toscano S; Dal Monte PR
    Minerva Med; 1972 Jul; 63(53):2861-72. PubMed ID: 5049878
    [No Abstract]   [Full Text] [Related]  

  • 29. [The behavior of the sulfobromophthalein chromoelimination curves subjects with ethylic hepatopathy treated with a liver extract enriched with nucleosides of the pyrimidine series and ith cyanocobalamine].
    D'Agostino F
    Minerva Med; 1970 Oct; 61(87):4893-901. PubMed ID: 5488540
    [No Abstract]   [Full Text] [Related]  

  • 30. [Proposed biotherapy of hyperlipidemia].
    Girotto T; Longo O
    Clin Ter; 1981 Mar; 96(6):393-604. PubMed ID: 7285525
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 32. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G; Malaguti P; Zincati GC
    Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of parenteral administration of hepatotropic preparation with dynamotropic properties in patients with liver diseases].
    Rottini E; Scianaro L
    Clin Ter; 1969 Oct; 51(1):49-61. PubMed ID: 5364033
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
    Heinrich HC
    Munch Med Wochenschr; 1968 Oct; 110(40):2311-2. PubMed ID: 5761604
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
    Wildhirt E
    Munch Med Wochenschr; 1968 Oct; 110(40):2313-4. PubMed ID: 5761605
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of neonatal jaundice with the administration of Toxepase Complex to pregnant women with edema-proteinuria-hypertension (EPH) gestosis].
    Cilotti R; Trincavelli M
    Minerva Ginecol; 1977 Mar; 29(3):233-44. PubMed ID: 577301
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of alcoholic liver disease: studies of 10 cases].
    Silvi G; Stellato S
    Clin Ter; 1978 Feb; 84(3):275-82. PubMed ID: 639480
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatotropic and proteo-anabolic therapeutic effects of a total hepatic preparation with a constant titer of natural coenzymatic cobalamin].
    Guidetti E; Vacha R; Vacha G
    Clin Ter; 1969 May; 49(4):323-36. PubMed ID: 5795020
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepa-listrocol in the therapy of chronic inflammatory liver diseases].
    Baum HH
    Landarzt; 1967 Apr; 43(11):530-3. PubMed ID: 5585071
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biological evaluation of liver protective agents with special consideration of liver preparations. 9. Practical use of prepared methods for biological evaluation of commercial liver preparations].
    Dressel H; Richter J
    Pharmazie; 1969 Sep; 24(9):555-66. PubMed ID: 5368430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.